Why an analyst bullish on Gilead says antiviral drug ‘won’t solve’ COVID-19

  • 📰 MarketWatch
  • ⏱ Reading Time:
  • 43 sec. here
  • 2 min. at publisher
  • 📊 Quality Score:
  • News: 20%
  • Publisher: 97%

United States Headlines News

United States Latest News,United States Headlines

“Remdesivir is not a silver bullet,” an analyst said.

Stat News, an award-winning publication for medical news, reported that a Chicago hospital treating severe COVID-19 patients with the antiviral medicine remdesivir is seeing rapid recoveries in fever and respiratory symptoms.

So, is this it? Is the end of the coronavirus crisis simply a matter of Gilead wrapping up the trial, submitting the proper paperwork and scaling up manufacturing? Raffat notes that the study specifically excluded patients on mechanical ventilation. Moreover, an earlier study on Chinese patients wasn’t stopped for efficacy reasons. Unlike the Chicago study, the China trial tested patients given a placebo.

Raffat said there should be cautious optimism around remdesivir, which is administered intravenously.Gilead itself says Phase 3 trial data to be available at the end of April and data from other studies to be available in May. “Anecdotal reports, while encouraging, do not provide the statistical power necessary to determine the safety and efficacy profile of remdesivir as a treatment for COVID-19,” the company said.

 

Thank you for your comment. Your comment will be published after being reviewed.
Please try again later.

This drug has been known about for a long time now. It has known side effects as well. That, coupled with some strange call option activity on GILD, seems to suggest that the SEC should be snooping around on this one.

Because he's deep state and wants the economy to crash...

We have summarized this news so that you can read it quickly. If you are interested in the news, you can read the full text here. Read more:

 /  🏆 3. in US

United States Latest News, United States Headlines

Similar News:You can also read news stories similar to this one that we have collected from other news sources.

Why Ventilators May Not Be Working as Well for COVID-19 Patients As Doctors HopedDoctors are reporting high death rates for COVID-19 patients on ventilators, leading some to question whether they should be used at all. Lets start with what we actually do know...
Source: YahooNews - 🏆 380. / 59 Read more »

Why Did The World Shut Down For COVID-19 But Not Ebola, SARS Or Swine Flu?We’re currently battling a global pandemic unlike any we’ve seen in over a century. But it’s also not the first modern virus we’ve faced. Wow u actually asked an intelligent question ABC. Didn't think it was possible Let me break it down for those that do not read. SARS and MERS: Deadly, but not easily spread Swine flu: Easily spread, but not as deadly Ebola: Very severe, but hard to contract Because too many white people were getting sick.
Source: ABC - 🏆 471. / 51 Read more »

Why COVID-19 Is Making You Act Like a Teenager AgainWhy You’re Regressing to Your Teenage Self During the COVID-19 Outbreak
Source: TIMEHealth - 🏆 121. / 63 Read more »

Why Did The World Shut Down For COVID-19 But Not Ebola, SARS Or Swine Flu?We’re currently battling a global pandemic unlike any we’ve seen in over a century. But it’s also not the first modern virus we’ve faced. FiveThirtyEight FiveThirtyEight Ebola mainly killed Africans so nobody cared FiveThirtyEight ABC, you got the money. Go do the research.
Source: ABC - 🏆 471. / 51 Read more »